• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Articles

Review Article

The Effects of Inspiratory Muscle Training in Individuals With Cervical Spinal Cord Injuries: A Systematic Review and Meta-Analysis

Dat Huu Tran, MD, MSc1,2orcid, Ha Thi Le, MD, MSc3,4orcid, Tho Thi Quynh Chu, MD, MSc5orcid, Hung Thi Cam Pham, MD, PhD3orcid, Anh Ngoc Van Le, MD, MSc2,6orcid
Annals of Rehabilitation Medicine 2025;49(3):152-163.
Published online: June 17, 2025

1Department of Rehabilitation, Vinmec Times City International Hospital, Hanoi, Vietnam

2Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

3Department of Rehabilitation, Haiduong Medical Technical University, Haiduong, Vietnam

4Niigata University of Health and Welfare, Niigata, Japan

5Department of Rehabilitation Science, Graduate School of Health Sciences, Kobe University, Kobe, Japan

6Department of Ophthalmology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam

Correspondence: Dat Huu Tran Department of Rehabilitation, Vinmec Times City International Hospital, 458 Minh Khai, Hai Ba Trung, Hanoi 100000, Vietnam. Tel: +84-333602710 Fax: +84-439743557 E-mail: tranhuudathmu@gmail.com
• Received: January 13, 2025   • Revised: April 8, 2025   • Accepted: May 12, 2025

© 2025 by Korean Academy of Rehabilitation Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 832 Views
  • 34 Download
prev next
  • The effect of inspiratory muscle training (IMT) on cervical spinal cord injury (SCI) remains controversial. This study aimed to assess the efficacy of IMT in enhancing breathing muscle strength, pulmonary function, and quality of life (QoL) among patients with cervical SCI. A search was performed using the PubMed, Cochrane Library, Scopus, Embase, and Web of Science databases through December 2023. This review was conducted according to PRISMA guidelines and the Cochrane Library Handbook. The meta-analysis used mean differences (MDs) or standardized mean differences to pool the results. The Risk of Bias 2 and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) were used to assess the methodological quality of the included studies. This systematic review included five randomized controlled trials (202 participants). The results of the meta-analysis showed that IMT significantly improved maximal inspiratory pressure (MIP) with MD 12.13 cmH2O (95% confidence interval [CI] 4.22 to 20.03), maximal expiratory pressure (MEP) with MD 8.98 cmH2O (95% CI 6.96 to 11.00), and vital capacity (VC) with MD 0.25 L (95% CI 0.21 to 0.28). There were no significant improvements in forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and QoL. The quality of the evidence ranged from very low to moderate, owing to bias and heterogeneity. Our results showed that IMT may improve MIP, MEP, and VC, but not FEV1, FVC, or QoL, in patients with cervical SCI. Further large-scale studies are required to determine this effect’s optimal dosage and duration.
Spinal cord injury (SCI) is defined as an injury to the spinal cord leading to neurological impairment, whether or not there is an associated disruption of the spinal column [1]. According to a report by the World Health Organization, approximately 15 million individuals are living with SCI, accounting for over 4.5 million years of life lived with a disability by 2021 [2]. This condition affect physical and psychological health [3,4]. Cervical SCI is the highest level of SCI and often affects the muscles involved in respiration, such as the diaphragm, abdominal muscles, intercostal muscles, and accessory respiratory muscles. This leads to a significant decline in respiratory function [5-7]. Pulmonary issues continue to be the primary cause of mortality after SCI because pulmonary function and the ability to clear secretions are impaired, particularly in people with higher levels and more complete injuries [7,8], especially in cervical SCI. Individuals with cervical SCI often have more severe impairment of lung function than those with thoracic or lumbar SCI because of the impact on the phrenic nerve.
Respiratory muscle training (RMT) is a promising method to improve the respiratory muscles in patients with SCI. It can be divided into two sub-methods: inspiratory muscle training (IMT) and expiratory muscle training (EMT). IMT, the most common form of RMT, has been suggested to improve inspiratory muscle strength by introducing resistance during inhalation [9]. Numerous studies have demonstrated the advantages of this therapeutic training in patients with SCI, including enhancement of inspiratory muscle strength, alleviation of breathlessness, and improved quality of life (QoL) [10-13]. EMT is another aspect of RMT that involves other muscles, such as the abdominal and internal intercostal muscles, which play vital roles in pulmonary clearance. The EMT significantly prevents phlegm stagnation and pneumonia, particularly in individuals with cervical SCI [14].
Several systematic reviews have assessed the overall impact of IMT on respiratory muscle power, endurance, and QoL in patients with SCI [15,16]. Although IMT has shown benefits in individuals with SCI, the extent to which these benefits apply specifically to patients with cervical SCI remains unclear. Unlike thoracic or lumbar SCI, where diaphragmatic function is largely preserved, cervical SCI often results in diaphragmatic weakness or paralysis, fundamentally altering the respiratory mechanics. This distinction raises critical clinical questions regarding the effectiveness of IMT in this subgroup and whether treatment strategies should be tailored accordingly. By isolating cervical SCI in our study, we aimed to determine whether IMT yields comparable outcomes and whether specific considerations are necessary to optimize respiratory rehabilitation in this population.
This systematic review and meta-analysis was conducted in accordance with PRISMA guidelines [17,18] and the Cochrane Handbook for Systematic Review of Intervention [19].
Eligible criteria
Following the PICO framework [19], the review’s inclusion criteria were as follows: (a) Study design: randomized controlled trials (RCTs). (b) Participants: individuals with SCI in the cervical region (from C1 to C8), encompassing both acute and chronic cases. (c) Intervention: the intervention protocol involved IMT and was compared with a control group (placebo, usual care, or other interventions). (d) Studies in English.
We excluded studies that explored the effect of IMT on respiratory conditions unrelated to SCI, such as chronic obstructive pulmonary disease, asthma, and other pulmonary diseases.
Outcome measures

Primary outcome

Maximal inspiratory pressure (MIP) measures inspiratory muscle power. It is a respiratory measurement that assesses the maximum force produced during the vigorous inhalation of a closed airway [20].

Secondary outcomes

(a) Maximal expiratory pressure (MEP) is another way to measure respiratory muscle strength but specifically focuses on the muscles involved in expiration activity. (b) Lung function: vital capacity (VC), forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1). (c) QoL: the studies utilized the Medical Outcomes Survey (Short Form 12 Health Survey or 36-Item Short Form Survey) [21,22].
Search strategy and study selection
We searched the PubMed, Cochrane Library, Scopus, Embase, and Web of Science databases. The final search was performed on December 20th, 2023. See the Supplementary Material S1 for the entire search strategy. We also reviewed the references of appropriate articles and literature reviews to identify further relevant published and unpublished studies.
Study selection: Two authors (DHT and HTL) reviewed each trial’s titles, abstracts, and full texts using predefined criteria. A third author (HTCP) resolved disagreements between the two reviewers, and the reasons for excluding certain studies were documented. We used the Covidence website (covidence.org) to conduct the screening.
Data collection and quality evaluation
Two authors separately retrieved the data using a standardized Excel form (Microsoft Corp.). Information was collected, including the principal author, year of publication, sample size, training protocol, and outcomes. Two authors independently employed The Cochrane Collaboration’s tool (Risk of Bias 2: RoB 2) [23] to evaluate the methodological quality of the included studies and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach [24] for the quality of evidence [25,26]. We the created a table of characteristics and summary findings based on the GRADE and analysis. Any disagreements were resolved by a third author (ANVL for RoB2 and TTQC for GRADE).
Statistical analysis
Two authors conducted analysis (DHT, HTL), and R programming language with the “meta” package was utilized to perform meta-analysis [27]. The results are presented as mean difference (MD) or standardized mean difference (SMD) with 95% confidence interval (CI). We used the chi-squared test and I2 test to evaluate heterogeneity. A fixed-effects model was used when I2 was <50%. Alternatively, a random effects model was used [28]. Subgroup analyses were conducted to confirm these results potentially. Statistical significance was set at p<0.05.
Study selection
From the electronic database search, 3,471 studies were initially identified. After screening and eliminating duplicates and irrelevant studies, 14 relevant studies were retrieved. After full-text reading, two studies were excluded because they did not utilize IMT [29,30], five studies were not RCTs [31-35], and two studies did not focus on cervical SCI [12,36]. This systematic review included five remaining studies (Fig. 1).
Study features
Table 1 lists the details of the included studies. The five included studies had 202 participants (100 in the treatment group and 102 in the control group), and the level of injury ranged from C4 to C8.
In five studies, the intervention was performed at any stage, including the acute, subacute, and chronic phases. Regarding the severity of the injury, almost all studies included patients with A or B according to the American Spinal Injury Association impairment scale, except for one trial [10], which included a C-type impairment.
Almost all studies mentioned medical instability or cardiopulmonary diseases, chest injuries, or mental illnesses as in their exclusion criteria.
Three trials utilized IMT devices equipped with resistance and spring-loaded mechanisms (POWERbreathe® Plus, Philips Threshold® IMT) [10,13,37], while the other two trials employed instrumentation that lacked spring-loaded features (Respifit S® electronic and DHD inspiratory muscle trainer) [38,39]. Participants were trained with resistance ranging from 60% to 80% of their MIP, except for the study using a DHD inspiratory muscle trainer, in which they started training at the slightest resistance and gradually increased it to reach the target resistance. Four studies involved training twice daily, and one involved training once daily. The follow-up duration ranged from 4 to 8 weeks.
Risk of bias
Evaluating potential bias was challenging because the trials’ detailed reports on their methods were insufficient. Figs. 2 and 3 show an overview of the evaluations of the risk of bias across all the trials incorporated.

Randomization process

All studies considered in the analysis were documented as randomized trials. Adequate allocation concealment was described in only two studies [10,39], whereas the randomization method in the remaining studies was unclear.

Blinding

Only one study demonstrated a clear strategy for blinding participants and assessors [10], while the remaining four studies only focused on blinding participants.

Incomplete outcome data

We identified two studies as having a high risk of incomplete outcome data [37,39] because they failed to provide information regarding the enrolled participants and did not complete the study. The dropout rates in those trials varied from 33% to 36%. Two studies were categorized as low risk due to their low dropout rates (<5%) [10,38].

Selective reporting and measurement methods

All included studies reported predefined outcomes and used appropriate and consistent measurement methods. Thus, we classified all five studies as having a low risk in these domains.

Overall

Only one study [10] showed a low potential for bias; the remaining studies had potential issues or a heightened bias risk.
Impact of IMT

Respiratory muscle strength

In all five studies [10,13,37-39], the impact of IMT on MIP and MEP after the intervention was documented. Respiratory pressures are presented as mean and standard deviation. Compared to control, meta-analysis indicated that IMT improved MIP meaningfully by an average of 12.13 cmH2O (95% CI 4.22 to 20.03, p<0.01; Fig. 4) and enhanced MEP notably by a MD of 8.98 cmH2O (95% CI 6.96 to 11.00, p<0.01; Fig. 5).

Lung function

Three parameters are often presented as lung function, including VC, FVC, and FEV1.
Four studies documented the effects of IMT on VC [10,37-39]. When compared to the control group, IMT showed a meaningful improvement on VC, MD 0.25 L (95% CI 0.21 to 0.28, p<0.01; Fig. 6).
Four studies assessed the effect of IMT on FVC [10,13,37,39]. Meta-analysis revealed that IMT enhanced FVC compared to the control, MD 0.43 L (95% CI -0.32 to 1.18), even though the disparity did not achieve statistical significance (p=0.26; Fig. 7).
Five studies examined the influence of IMT on FEV1 [10,13,37-39]. Meta-analysis indicated an improvement in FEV1, MD 0.27 L (95% CI -0.06 to 0.61) due to IMT, but the disparity did not reach statistical significance compared to the control groups (p=0.11; Fig. 8).

QoL

Two studies [10,38] involving 26 participants presented data on the effect of IMT on QoL. In comparison to control groups (Fig. 9), IMT did not improve QoL, showing a SMD of 0.00 (95% CI -0.14 to 0.15, p=0.90).

Subgroup analysis for the type of threshold devices

Three studies [10,13,37] with 166 participants that utilized a spring-loaded device showed a clinically relevant effect on MIP, with an MD of 8.44 cmH2O (95% CI 1.36 to 15.52; Fig. 10). In contrast, the change of MIP observed in the two remaining studies [38,39] using devices without a spring-loaded feature was insignificant, with an MD of 1.35 cmH2O (95% CI -8.05 to 10.75; Fig. 11).
Quality of evidence
Table 2 shows the evidence quality using the GRADE systems; the outcomes with MIP, MEP, and VC showed effectiveness with moderate-quality evidence. The outcomes of FVC and FEV1 showed that IMT might have an effect with low-quality evidence and no effect with very low evidence in the QoL outcome. Almost all outcomes had problems with the risk of bias. Other reasons that reduced the quality of evidence were inconsistency in FVC, FEV1, and QoL outcomes and imprecision with QoL outcomes because of the small sample size.
This meta-analysis focused on the efficacy of IMT for improving inspiratory muscle power, pulmonary function, and QoL in patients with cervical SCI. Our findings showed that IMT may improve respiratory muscle strength (including MIP and MEP) and VC. However, FVC, FEV1, and QoL were unaffected, with little evidence supporting these outcomes.
The meta-analysis with the largest sample size (n=202) focused on respiratory muscle strength. It showed a favorable effect in the intervention group compared to the control group, with MDs of 12.13 cmH2O for MIP and 8.98 cmH2O for MEP. This aligns with findings from numerous other systematic reviews investigating IMT in SCI [14,15,16,40], except for two that showed no effectiveness on MEP [15,16]. This could be because these studies investigated IMT in patients with SCI and those with cervical SCI. IMT directly strengthens inspiratory muscles, especially the diaphragm. As the inspiratory muscles become stronger, they generate higher inspiratory pressure, leading to better lung inflation. This can increase the lung volume (e.g., VC and inspiratory reserve volume), which might result in more effective and forceful expiratory efforts. When the lungs are fully inflated, elastic recoil is more significant during exhalation, contributing to a higher MEP [41]. Although the included trials did not show clinical outcomes such as pneumonia, sense of breathlessness, and peak cough flow, much evidence has demonstrated a correlation between respiratory muscle strength, especially inspiratory muscle power, and these outcomes. Indeed, improving MIP can help reduce the risk of pneumonia [42,43] and improve peak cough flow and secretion clearance in patients with spinal cord injuries [44]. IMT can improve the prognosis of patients with cervical SCI by enhancing respiratory muscle strength.
Regarding the intervention protocol, four studies reported an intensity ranging from 60% to 80% of MIP, categorized as moderate to high intensity, with a frequency of 4 to 5 days per week [10,13,37,38]. Only one study did not specify the exact intensity but reported a frequency of seven days per week [39], and that study showed that IMT did not significantly improve muscle strength. Previous studies have suggested moderate to high-intensity exercise is necessary to achieve the best outcomes [45]. Our meta-analysis showed that a protocol involving 70%–80% MIP with a frequency of 4–5 days per week provides the best results.
VC in individuals with tetraplegia declines notably over time, with a more pronounced decline occurring after 20 years post-injury [46]. In our systematic review, IMT effectively increased VC by a MD of 0.25 L. A systematic review by Berlowitz and Tamplin [40] conducted on 4 of 11 trials, also revealed evidence of a positive effect of RMT on VC in cervical SCI.
This meta-analysis did not show a significant effect of IMT on FEV1 or FVC. Similarly, four previous reviews showed that RMT did not affect FEV1 in SCI patients [14-16,40]. Regarding FVC, to our knowledge, little evidence mentions the effect of IMT on FVC; only one systematic review showed that RMT might affect FVC in SCI [14]. In our review, IMT was performed for a short duration, and the time from the onset of cervical SCI was heterogeneous. Hence, the changes in FVC and FEV1 were unclear, and the recovery phase was much longer than the intervention period [47,48]. To survey the actual effect, future research should be conducted with a longer intervention duration and more specific patients with a similar onset and level of injury. In summary, the results are unclear, and more evidence is needed to clarify the effectiveness of IMT on FEV1 and FVC.
In this meta-analysis, the change in QoL after the intervention was insignificant and remained nearly unchanged. This result is consistent with previous findings [14-16]. To explain this result, it is important to consider that individuals with cervical SCI experience numerous deficits, and their QoL is influenced by various factors, including the time since injury, adaptation to disability, general and mental health, social functioning, emotional issues, and pain [49]. Consequently, individuals with SCI may require multiple interventions to improve their QoL. Furthermore, an intervention duration of four to eight weeks of intervention may not be long enough to induce significant changes in QoL.
By comparing the effectiveness of different IMT devices on MIP and MEP, our results show that spring-loaded devices have clinically relevant effectiveness, whereas devices without a spring-loaded feature do not. This finding aligns with previous studies in patients with SCI [16]. This could be because spring-loaded devices provide consistent resistance and are ideal for inspiratory muscle strength training using structured programs [50]. These results suggest that interventions should involve a spring-loaded device to achieve better outcomes.
Based on these results, IMT effectively improved MIP, MEP, and VC in patients with cervical SCI. This suggests that IMT improves the clinical prognosis of pneumonia and coughing ability [42-44]. While this training method may not improve QoL, it is currently worth performing. Future research should focus on the effectiveness of IMT in other aspects of patients with SCI, such as endurance or daily life activities, or on combining IMT with EMT to evaluate their combined effects in clinical practice. The recommended device is a spring-loaded threshold device.
Limitations and suggestions

Limitations

Existing studies on IMT have limited sample sizes, and the training methods lack specificity, especially intensity and duration. In addition, this study has the following limitations: (i) This review incorporated only five studies, each with a relatively small sample size. Furthermore, the results exhibited considerable heterogeneity owing to significant differences in training duration and devices used. (ii) The study was conducted by searching only five databases, with a limitation in including English trials. (iii) Some studies experienced participant attrition or incomplete data, potentially leading to an elevated risk of bias. (iv) The review was not registered in PROSPERO.

Suggestions

IMT with spring-loaded devices should be used in clinical practice to provide more effective exercise. Second, for research, (i) additional large-scale and rigorous studies are necessary to strengthen this conclusion, define the optimal dosages and duration of the effect, and investigate whether IMT provides any sustained long-term functional benefits in patients with SCI; and (ii) other outcome measures related to ADL, activities, and cardiopulmonary endurance could be investigated.
In conclusion, IMT is worth performing in clinical practice based on evidence showing that it improves the strength of respiratory muscles and pulmonary function in patients with SCI by increasing MIP, MEP, and VC. However, there is insufficient evidence regarding the effectiveness of IMT in improving FEV1, FVC, and QoL. The spring-loaded devices substantially impacted the MIP and MEP, whereas the non-spring-loaded devices did not. Additional large-scale studies are necessary to define the optimal dosage and impact duration to investigate whether IMT provides sustained long-term functional benefits in patients with SCI.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING INFORMATION

None.

AUTHOR CONTRIBUTION

Conceptualization: Tran DH. Data curation: Tran DH, Le HT, Chu TTQ, Pham HTC, Le ANV. Formal analysis: Tran DH, Le HT, Le ANV. Methodology: Tran DH, Le HT, Chu TTQ, Pham HTC, Le ANV. Software: Le HT. Project administration: Tran DH. Validation: Chu TTQ. Writing – original draft: Tran DH. Writing – review & editing: Tran DH, Le HT, Chu TTQ, Pham HTC, Le ANV. Approval of final manuscript: all authors.

Supplementary materials can be found via https://doi.org/10.5535/arm.250013.

Supplementary Material S1.

Search strategy
arm-250013-Supplementary-Material-S1.pdf
Fig. 1.
PRISMA diagram. This figure shows the process of study searching and selection. IMT, inspiratory muscle training; RCT, randomized controlled trial.
arm-250013f1.jpg
Fig. 2.
Bias risk evaluated using the Risk of Bias 2 (RoB 2) tool. This figure displays the results of the summary of the bias risk assessments for each included study, organized into different domains of bias using the RoB 2 tool. Each domain is categorized by colors and patterns representing different levels of bias risk (low risk, some concerns, high risk).
arm-250013f2.jpg
Fig. 3.
Risk of bias overview graph based on each domain. The graph represents each domain as a separate bar, with the length and color indicating the level of bias risk in that domain.
arm-250013f3.jpg
Fig. 4.
Meta-analysis results for maximal inspiratory pressure (MIP). This figure provides a visual summary of the meta-analysis results specifically related to MIP. SD, standard deviation; CI, confidence interval.
arm-250013f4.jpg
Fig. 5.
Meta-analysis results for maximal expiratory pressure (MEP). This figure shows the forest plot of meta-analysis results related to MEP. SD, standard deviation; CI, confidence interval.
arm-250013f5.jpg
Fig. 6.
Meta-analysis results for vital capacity (VC). The forest plot shows the results of the meta-analysis for VC. SD, standard deviation; CI, confidence interval.
arm-250013f6.jpg
Fig. 7.
Meta-analysis results for forced vital capacity (FVC). The forest plot shows the results of the meta-analysis for FVC. SD, standard deviation; CI, confidence interval.
arm-250013f7.jpg
Fig. 8.
Meta-analysis results for forced expiratory volume in one second (FEV1). This figure shows the forest plot of meta-analysis results related to FEV1. SD, standard deviation; CI, confidence interval.
arm-250013f8.jpg
Fig. 9.
Meta-analysis results for quality of life (QoL). This figure represents the forest plot of meta-analysis results for QoL. SMD, standardized mean difference; SE, standard error; CI, confidence interval.
arm-250013f9.jpg
Fig. 10.
Subgroup analysis results of spring-loaded devices on maximal inspiratory pressure (MIP). This figure displays the forest plot of the subgroup meta-analysis results for the impact of training with spring-loaded devices on MIP. SD, standard deviation; CI, confidence interval.
arm-250013f10.jpg
Fig. 11.
Subgroup analysis results of non-spring-loaded devices on maximal inspiratory pressure (MIP). This figure shows the forest plot of the subgroup meta-analysis results for the impact of training with spring-loaded devices on MIP. SD, standard deviation; CI, confidence interval.
arm-250013f11.jpg
arm-250013f12.jpg
Table 1.
Features of the trials included
Reference Sex (M/F) Sample size (T/C) Stage of injury Level of injury Training protocol Control Intervention duration (wk) Outcome measures
Liaw et al., 2000 [39] 16/4 10/10 Acute, sub-acute C4–C7 Training commenced with the lowest level of inspiratory resistance (blue, 7 mm). Duration: 15–20 minutes, twice a day, 7 days/wk Usual care 6 MIP, MEP, VC, FVC, FEV1
Mueller et al., 2013 [38] 12/4 8/8 Sub-acute, chronic C5–C8 80% MIP, 90 repetitions for 10 minutes session, 4 days/wk Placebo 8 MIP, MEP, VC, FEV1, QoL (SF-12)
West et al., 2014 [13] 9/1 5/5 Chronic C5–C7 60% MIP, 30 repetitions each session, twice a day, 5 days/wk Placebo 6 MIP, MEP, FVC, FEV1
Boswell-Ruys et al., 2020 [10] 57/3 29/31 Acute, sub-acute, chronic C4–C7 80% MIP, 3–5 sets of 12 breaths with a rest period of 2 minutes, twice daily, for 5 days a week Sham intervention 6 MIP, MEP, VC, FVC, FEV1, QoL (SF-36)
Sikka et al., 2021 [37] 72/24 48/48 Acute C4–C7 70% MIP, 6 sets of 12 repetitions each session, twice a day, 5 days/wk Conventional intervention 4 MIP, MEP, VC, FVC, FEV1

M/F, male/female; T/C, treatment/control; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; VC, vital capacity; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; QoL, quality of life; SF-12, Short Form 12 Health Survey; SF-36, 36-Item Short Form Survey.

Table 2.
Summary of findings: comparing inspiratory muscle training to a control group in individuals with cervical SCI
Outcome measures Results (95% CI) No. of participants GRADE Comments
MIP MD 12.13 cmH2O (4.22 higher to 20.03 higher) 202 (5 RCTs) ⨁⨁⨁◯ IMT improves MIP
Follow-up: 4 to 8 weeks Moderatea
MEP MD 8.98 cmH2O (6.96 higher to 11.00 higher) 202 (5 RCTs) ⨁⨁⨁◯ IMT improves MEP
Follow-up: 4 to 8 weeks Moderatea
VC MD 0.25 L (0.21 higher to 0.28 higher) 192 (4 RCTs) ⨁⨁⨁◯ IMT improves VC
Follow-up: 4 to 8 weeks Moderatea
FVC MD 0.43 L (0.32 lower to 1.18 higher) 186 (4 RCTs) ⨁⨁◯◯ The effect of IMT on FVC is uncertain
Follow-up: 4 to 6 weeks Lowa,b
FEV1 MD 0.27 L (0.06 lower to 0.61 higher) 202 (5 RCTs) ⨁⨁◯◯ The effect of IMT on FEV1 is uncertain
Follow-up: 4 to 8 weeks Lowa,b
QoL SMD 0.00 (0.14 lower to 0.15 higher) 76 (2 RCTs) ⨁◯◯◯ The effect of IMT on QoL is uncertain
Follow-up: 6 to 8 weeks Very lowa,b,c

High quality: We have strong confidence that the actual impact closely mirrors the estimated impact.

Moderate quality: We hold the belief that the actual impact is likely in proximity to the estimated impact.

Low quality: The actual impact could be notably distinct from the estimated impact.

Very low quality: The actual effect is likely significantly distinct from the estimated impact.

SCI, spinal cord injury; IMT, inspiratory muscle training; CI, confidence interval; GRADE: Grading of Recommendations, Assessment, Development, and Evaluation; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; VC, vital capacity; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; QoL, quality of life; MD, mean difference; SMD, standardized mean difference; RCTs, randomized controlled trials.

aDowngrade 1 level due to risk of bias.

bDowngrade 1 level due to inconsistency.

cDowngrade 1 level due to imprecision.

  • 1. Sloan TB. Chapter 183 - Spinal cord injury. In: Atlee JL, editor. Complications in anesthesia. 2nd ed. Saunders; 2007. p. 737-40.
  • 2. Spinal cord injury [Internet]. World Health Organization; 2024 [cited 2024 May 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury#:~:text=Global%20estimates%20suggest%20that%20in,YLDs%20attributed%20to%20this%20demographic
  • 3. Strøm V, Månum G, Arora M, Joseph C, Kyriakides A, Le Fort M, et al. Physical health conditions in persons with spinal cord injury across 21 countries worldwide. J Rehabil Med 2022;54:jrm00302.
  • 4. Budd MA, Gater DR Jr, Channell I. Psychosocial consequences of spinal cord injury: a narrative review. J Pers Med 2022;12:1178.
  • 5. Hagen EM. Acute complications of spinal cord injuries. World J Orthop 2015;6:17-23.
  • 6. Nakashima H, Yukawa Y, Imagama S, Ito K, Hida T, Machino M, et al. Characterizing the need for tracheostomy placement and decannulation after cervical spinal cord injury. Eur Spine J 2013;22:1526-32.
  • 7. Galeiras Vázquez R, Rascado Sedes P, Mourelo Fariña M, Montoto Marqués A, Ferreiro Velasco ME. Respiratory management in the patient with spinal cord injury. Biomed Res Int 2013;2013:168757.
  • 8. Berlowitz DJ, Wadsworth B, Ross J. Respiratory problems and management in people with spinal cord injury. Breathe (Sheff) 2016;12:328-40.
  • 9. Chung Y, Huang TY, Liao YH, Kuo YC. 12-Week inspiratory muscle training improves respiratory muscle strength in adult patients with stable asthma: a randomized controlled trial. Int J Environ Res Public Health 2021;18:3267.
  • 10. Boswell-Ruys CL, Lewis CRH, Wijeysuriya NS, McBain RA, Lee BB, McKenzie DK, et al. Impact of respiratory muscle training on respiratory muscle strength, respiratory function and quality of life in individuals with tetraplegia: a randomised clinical trial. Thorax 2020;75:279-88.
  • 11. Soumyashree S, Kaur J. Effect of inspiratory muscle training (IMT) on aerobic capacity, respiratory muscle strength and rate of perceived exertion in paraplegics. J Spinal Cord Med 2020;43:53-9.
  • 12. Postma K, Haisma JA, Hopman MT, Bergen MP, Stam HJ, Bussmann JB. Resistive inspiratory muscle training in people with spinal cord injury during inpatient rehabilitation: a randomized controlled trial. Phys Ther 2014;94:1709-19.
  • 13. West CR, Taylor BJ, Campbell IG, Romer LM. Effects of inspiratory muscle training on exercise responses in Paralympic athletes with cervical spinal cord injury. Scand J Med Sci Sports 2014;24:764-72.
  • 14. Wang X, Zhang N, Xu Y. Effects of respiratory muscle training on pulmonary function in individuals with spinal cord injury: an updated meta-analysis. Biomed Res Int 2020;2020:7530498.
  • 15. de Araújo Morais L, Cipriano G Jr, Martins WR, Chiappa GR, Formiga MF, Cipriano GFB. Inspiratory muscle training on quality of life in individuals with spinal cord injury: a systematic review and meta-analysis. Spinal Cord 2023;61:359-67.
  • 16. Woods A, Gustafson O, Williams M, Stiger R. The effects of inspiratory muscle training on inspiratory muscle strength, lung function and quality of life in adults with spinal cord injuries: a systematic review and Meta-analysis. Disabil Rehabil 2023;45:2703-14.
  • 17. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12.
  • 18. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160.
  • 19. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from: www.training.cochrane.org/handbook
  • 20. Sachs MC, Enright PL, Hinckley Stukovsky KD, Jiang R, Barr RG; Multi-Ethnic Study of Atherosclerosis Lung Study. Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups. Respir Care 2009;54:1321-8.
  • 21. Turner-Bowker D, Hogue SJ. Short Form 12 Health Survey (SF-12). In: Michalos AC, editor. Encyclopedia of quality of life and well-being research. Springer; 2014. p. 5954-7.
  • 22. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
  • 23. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.
  • 24. Prime MUaE. GRADEpro GDT: GRADEpro Guideline Development Tool [software]. 2024 [cited 2024 May 10]. Available from: gradepro.org
  • 25. Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol 2013;66:736-42. quiz 742.e1-5.
  • 26. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
  • 27. Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 2019;22:153-60.
  • 28. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010;1:97-111.
  • 29. Wang HC, Lin YT, Huang CC, Lin MC, Liaw MY, Lu CH. Effects of respiratory muscle training on baroreflex sensitivity, respiratory function, and serum oxidative stress in acute cervical spinal cord injury. J Pers Med 2021;11:377.
  • 30. Crane L, Klerk K, Ruhl A, Warner P, Ruhl C, Roach KE. The effect of exercise training on pulmonary function in persons with quadriplegia. Paraplegia 1994;32:435-41.
  • 31. Rutchik A, Weissman AR, Almenoff PL, Spungen AM, Bauman WA, Grimm DR. Resistive inspiratory muscle training in subjects with chronic cervical spinal cord injury. Arch Phys Med Rehabil 1998;79:293-7.
  • 32. Cheshire DJ, Flack WJ. The use of operant conditioning techniques in the respiratory rehabilitation of the tetraplegic. Paraplegia 1978;16:162-74.
  • 33. Ehrlich M, Manns PJ, Poulin C. Respiratory training for a person with C3-C4 tetraplegia. Aust J Physiother 1999;45:301-7.
  • 34. Amarsheda S, Bhise AR, Patel SG. Efficacy of inspiratory muscle trainer and incentive spirometer on inspiratory muscle strength in patients with tetraplegia in Indian setting. Arch Phys Med Rehabilit 2016;97:e49.
  • 35. Uijl SG, Houtman S, Folgering HT, Hopman MT. Training of the respiratory muscles in individuals with tetraplegia. Spinal Cord 1999;37:575-9.
  • 36. Raab AM, Krebs J, Perret C, Pfister M, Hopman M, Mueller G. Evaluation of a clinical implementation of a respiratory muscle training group during spinal cord injury rehabilitation. Spinal Cord Ser Cases 2018;4:40.
  • 37. Sikka G, Yadav J, Singh R, K B G. Effect of 4 weeks resistive inspiratory muscle training on respiratory functions in patients with tetraplegia during in-patient rehabilitation. Int J Res Pharm Sci 2021;12:536-43.
  • 38. Mueller G, Hopman MT, Perret C. Comparison of respiratory muscle training methods in individuals with motor and sensory complete tetraplegia: a randomized controlled trial. J Rehabil Med 2013;45:248-53.
  • 39. Liaw MY, Lin MC, Cheng PT, Wong MK, Tang FT. Resistive inspiratory muscle training: its effectiveness in patients with acute complete cervical cord injury. Arch Phys Med Rehabil 2000;81:752-6.
  • 40. Berlowitz DJ, Tamplin J. Respiratory muscle training for cervical spinal cord injury. Cochrane Database Syst Rev 2013;2013:CD008507.
  • 41. Gold WM, Koth LL. 25 - Pulmonary function testing. In: Broaddus VC, Mason RJ, Ernst JD, King TE, Lazarus SC, Murray JF, et al., editors. Murray and Nadel’s textbook of respiratory medicine. 6th ed. Elsevier; 2016. p. 407-35.e18.
  • 42. Mueller G, Berlowitz DJ, Raab AM, Postma K, Gobets D, Huber B, et al. Incidence and risk factors of pneumonia in individuals with acute spinal cord injury: a multi-national, multi-center, prospective cohort study. Arch Phys Med Rehabil 2024;105:884-91.
  • 43. Raab AM, Krebs J, Perret C, Michel F, Hopman MT, Mueller G. Maximum inspiratory pressure is a discriminator of pneumonia in individuals with spinal-cord injury. Respir Care 2016;61:1636-43.
  • 44. Kang SW, Shin JC, Park CI, Moon JH, Rha DW, Cho DH. Relationship between inspiratory muscle strength and cough capacity in cervical spinal cord injured patients. Spinal Cord 2006;44:242-8.
  • 45. McConnell A. Respiratory muscle training: theory and practice. Churchill Livingstone; 2013. p. 305-11.
  • 46. Tow AM, Graves DE, Carter RE. Vital capacity in tetraplegics twenty years and beyond. Spinal Cord 2001;39:139-44.
  • 47. Burns AS, Marino RJ, Flanders AE, Flett H. Clinical diagnosis and prognosis following spinal cord injury. Handb Clin Neurol 2012;109:47-62.
  • 48. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007;45:190-205.
  • 49. Sturm C, Gutenbrunner CM, Egen C, Geng V, Lemhöfer C, Kalke YB, et al. Which factors have an association to the Quality of Life (QoL) of people with acquired Spinal Cord Injury (SCI)? A cross-sectional explorative observational study. Spinal Cord 2021;59:925-32.
  • 50. Menzes KKP, Nascimento LR, Avelino PR, Polese JC, Salmela LFT. A review on respiratory muscle training devices. J Pulm Respir Med 2018;8:1000451.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      The Effects of Inspiratory Muscle Training in Individuals With Cervical Spinal Cord Injuries: A Systematic Review and Meta-Analysis
      Ann Rehabil Med. 2025;49(3):152-163.   Published online June 17, 2025
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      The Effects of Inspiratory Muscle Training in Individuals With Cervical Spinal Cord Injuries: A Systematic Review and Meta-Analysis
      Ann Rehabil Med. 2025;49(3):152-163.   Published online June 17, 2025
      Close

      Figure

      • 0
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      The Effects of Inspiratory Muscle Training in Individuals With Cervical Spinal Cord Injuries: A Systematic Review and Meta-Analysis
      Image Image Image Image Image Image Image Image Image Image Image Image
      Fig. 1. PRISMA diagram. This figure shows the process of study searching and selection. IMT, inspiratory muscle training; RCT, randomized controlled trial.
      Fig. 2. Bias risk evaluated using the Risk of Bias 2 (RoB 2) tool. This figure displays the results of the summary of the bias risk assessments for each included study, organized into different domains of bias using the RoB 2 tool. Each domain is categorized by colors and patterns representing different levels of bias risk (low risk, some concerns, high risk).
      Fig. 3. Risk of bias overview graph based on each domain. The graph represents each domain as a separate bar, with the length and color indicating the level of bias risk in that domain.
      Fig. 4. Meta-analysis results for maximal inspiratory pressure (MIP). This figure provides a visual summary of the meta-analysis results specifically related to MIP. SD, standard deviation; CI, confidence interval.
      Fig. 5. Meta-analysis results for maximal expiratory pressure (MEP). This figure shows the forest plot of meta-analysis results related to MEP. SD, standard deviation; CI, confidence interval.
      Fig. 6. Meta-analysis results for vital capacity (VC). The forest plot shows the results of the meta-analysis for VC. SD, standard deviation; CI, confidence interval.
      Fig. 7. Meta-analysis results for forced vital capacity (FVC). The forest plot shows the results of the meta-analysis for FVC. SD, standard deviation; CI, confidence interval.
      Fig. 8. Meta-analysis results for forced expiratory volume in one second (FEV1). This figure shows the forest plot of meta-analysis results related to FEV1. SD, standard deviation; CI, confidence interval.
      Fig. 9. Meta-analysis results for quality of life (QoL). This figure represents the forest plot of meta-analysis results for QoL. SMD, standardized mean difference; SE, standard error; CI, confidence interval.
      Fig. 10. Subgroup analysis results of spring-loaded devices on maximal inspiratory pressure (MIP). This figure displays the forest plot of the subgroup meta-analysis results for the impact of training with spring-loaded devices on MIP. SD, standard deviation; CI, confidence interval.
      Fig. 11. Subgroup analysis results of non-spring-loaded devices on maximal inspiratory pressure (MIP). This figure shows the forest plot of the subgroup meta-analysis results for the impact of training with spring-loaded devices on MIP. SD, standard deviation; CI, confidence interval.
      Graphical abstract
      The Effects of Inspiratory Muscle Training in Individuals With Cervical Spinal Cord Injuries: A Systematic Review and Meta-Analysis
      Reference Sex (M/F) Sample size (T/C) Stage of injury Level of injury Training protocol Control Intervention duration (wk) Outcome measures
      Liaw et al., 2000 [39] 16/4 10/10 Acute, sub-acute C4–C7 Training commenced with the lowest level of inspiratory resistance (blue, 7 mm). Duration: 15–20 minutes, twice a day, 7 days/wk Usual care 6 MIP, MEP, VC, FVC, FEV1
      Mueller et al., 2013 [38] 12/4 8/8 Sub-acute, chronic C5–C8 80% MIP, 90 repetitions for 10 minutes session, 4 days/wk Placebo 8 MIP, MEP, VC, FEV1, QoL (SF-12)
      West et al., 2014 [13] 9/1 5/5 Chronic C5–C7 60% MIP, 30 repetitions each session, twice a day, 5 days/wk Placebo 6 MIP, MEP, FVC, FEV1
      Boswell-Ruys et al., 2020 [10] 57/3 29/31 Acute, sub-acute, chronic C4–C7 80% MIP, 3–5 sets of 12 breaths with a rest period of 2 minutes, twice daily, for 5 days a week Sham intervention 6 MIP, MEP, VC, FVC, FEV1, QoL (SF-36)
      Sikka et al., 2021 [37] 72/24 48/48 Acute C4–C7 70% MIP, 6 sets of 12 repetitions each session, twice a day, 5 days/wk Conventional intervention 4 MIP, MEP, VC, FVC, FEV1
      Outcome measures Results (95% CI) No. of participants GRADE Comments
      MIP MD 12.13 cmH2O (4.22 higher to 20.03 higher) 202 (5 RCTs) ⨁⨁⨁◯ IMT improves MIP
      Follow-up: 4 to 8 weeks Moderatea
      MEP MD 8.98 cmH2O (6.96 higher to 11.00 higher) 202 (5 RCTs) ⨁⨁⨁◯ IMT improves MEP
      Follow-up: 4 to 8 weeks Moderatea
      VC MD 0.25 L (0.21 higher to 0.28 higher) 192 (4 RCTs) ⨁⨁⨁◯ IMT improves VC
      Follow-up: 4 to 8 weeks Moderatea
      FVC MD 0.43 L (0.32 lower to 1.18 higher) 186 (4 RCTs) ⨁⨁◯◯ The effect of IMT on FVC is uncertain
      Follow-up: 4 to 6 weeks Lowa,b
      FEV1 MD 0.27 L (0.06 lower to 0.61 higher) 202 (5 RCTs) ⨁⨁◯◯ The effect of IMT on FEV1 is uncertain
      Follow-up: 4 to 8 weeks Lowa,b
      QoL SMD 0.00 (0.14 lower to 0.15 higher) 76 (2 RCTs) ⨁◯◯◯ The effect of IMT on QoL is uncertain
      Follow-up: 6 to 8 weeks Very lowa,b,c
      Table 1. Features of the trials included

      M/F, male/female; T/C, treatment/control; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; VC, vital capacity; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; QoL, quality of life; SF-12, Short Form 12 Health Survey; SF-36, 36-Item Short Form Survey.

      Table 2. Summary of findings: comparing inspiratory muscle training to a control group in individuals with cervical SCI

      High quality: We have strong confidence that the actual impact closely mirrors the estimated impact.

      Moderate quality: We hold the belief that the actual impact is likely in proximity to the estimated impact.

      Low quality: The actual impact could be notably distinct from the estimated impact.

      Very low quality: The actual effect is likely significantly distinct from the estimated impact.

      SCI, spinal cord injury; IMT, inspiratory muscle training; CI, confidence interval; GRADE: Grading of Recommendations, Assessment, Development, and Evaluation; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; VC, vital capacity; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; QoL, quality of life; MD, mean difference; SMD, standardized mean difference; RCTs, randomized controlled trials.

      Downgrade 1 level due to risk of bias.

      Downgrade 1 level due to inconsistency.

      Downgrade 1 level due to imprecision.

      TOP